Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
[This corrects the article DOI: 10.1371/journal.pone.0251716.].
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0253252 |
| _version_ | 1818824962102788096 |
|---|---|
| author | PLOS ONE Staff |
| author_facet | PLOS ONE Staff |
| author_sort | PLOS ONE Staff |
| collection | DOAJ |
| description | [This corrects the article DOI: 10.1371/journal.pone.0251716.]. |
| first_indexed | 2024-12-19T00:04:12Z |
| format | Article |
| id | doaj.art-24c773a4e3884442b875be1f104af87b |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-19T00:04:12Z |
| publishDate | 2021-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-24c773a4e3884442b875be1f104af87b2022-12-21T20:46:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01166e025325210.1371/journal.pone.0253252Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.PLOS ONE Staff[This corrects the article DOI: 10.1371/journal.pone.0251716.].https://doi.org/10.1371/journal.pone.0253252 |
| spellingShingle | PLOS ONE Staff Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. PLoS ONE |
| title | Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. |
| title_full | Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. |
| title_fullStr | Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. |
| title_full_unstemmed | Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. |
| title_short | Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. |
| title_sort | correction 2 day versus c reactive protein guided antibiotherapy with levofloxacin in acute copd exacerbation a randomized controlled trial |
| url | https://doi.org/10.1371/journal.pone.0253252 |
| work_keys_str_mv | AT plosonestaff correction2dayversuscreactiveproteinguidedantibiotherapywithlevofloxacininacutecopdexacerbationarandomizedcontrolledtrial |